Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CiPA Trial: Effect of Citalopram on Chest Pain in Patients with Achalasia
2019-001202-14Phase 4Active
- Sponsor
- Amsterdam University Medical Center
- Start
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in achalasia comparing Citalopram with Placebo (2 arms). Primary endpoint: Global assessment of chest pain at 6 weeks. Started Apr 2019; status: active.
02
Drugs
citalopram
03
Conditions
achalasia
Beyond the preview
Go deeper on 2019-001202-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-001202-14.